{"data":{"id":"us/21-cfr-350.3","jurisdiction":"us","citation":"21 CFR 350.3","heading":"Definition.","body":"As used in this part:\nAntiperspirant. A drug product applied topically that reduces the production of perspiration (sweat) at that site.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 350—ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart A—General Provisions"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"355831df4f82928a9fe022cc2312bd35515bb97301dc3921daeb6aa2c8d9e8cc","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-350.1","next":"us/21-cfr-350.10"},"notice":"GroundRules: Original legal text. Not legal advice."}